米CFTC、無期限先物を巡る重大な争いでCMEの法的立場を突っぱねる

The U.S. Commodity Futures Trading Commission has firmly rejected the legal stance taken by CME Group in a high-stakes disagreement regarding perpetual futures contracts. The regulatory agency argued that CME has failed to sufficiently demonstrate that recent approvals for competing bitcoin perpetual products have caused direct financial or operational harm. Perpetual futures remain one of the most heavily traded instruments in the global cryptocurrency ecosystem due to their high liquidity and leverage options. Historically, U.S. regulatory scrutiny has kept many of these derivative products offshore, forcing domestic traders to seek alternative venues. A definitive legal ruling in this matter could reshape how derivative exchanges operate within the strict boundaries of American regulatory oversight. Industry stakeholders are monitoring the litigation closely as a bellwether for future crypto derivative product launches.